The Latest Headlines at American Banking and Market News
Short Interest in Wharf Real Estate Investment Company Limited (OTCMKTS:WRFRF) Increases By 19.7%
Wharf Real Estate Investment Company Limited (OTCMKTS:WRFRF – Get Free Report) was the target of a significant growth in short interest in April. As of April 30th, there was short interest totalling 8,069,900 shares, a growth... More of this article »
Westhaven Gold Corp. (OTCMKTS:WTHVF) Short Interest Up 36.1% in April
Westhaven Gold Corp. (OTCMKTS:WTHVF – Get Free Report) saw a significant growth in short interest in April. As of April 30th, there was short interest totalling 26,000 shares, a growth of 36.1% from the April 15th total of 19,100... More of this article »
WSP Global Inc. (OTCMKTS:WSPOF) Short Interest Update
WSP Global Inc. (OTCMKTS:WSPOF – Get Free Report) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 274,000 shares, a drop of 16.5% from... More of this article »
Whitbread plc (OTCMKTS:WTBCF) Short Interest Down 18.7% in April
Whitbread plc (OTCMKTS:WTBCF – Get Free Report) was the recipient of a significant drop in short interest during the month of April. As of April 30th, there was short interest totalling 83,600 shares, a drop of 18.7% from the... More of this article »
Q4 2024 EPS Estimates for Western Alliance Bancorporation (NYSE:WAL) Reduced by Wedbush
Western Alliance Bancorporation (NYSE:WAL – Free Report) – Research analysts at Wedbush dropped their Q4 2024 earnings per share (EPS) estimates for Western Alliance Bancorporation in a research report issued on Wednesday,... More of this article »
B2Gold Corp. to Post Q4 2024 Earnings of $0.07 Per Share, Cormark Forecasts (NYSEAMERICAN:BTG)
B2Gold Corp. (NYSEAMERICAN:BTG – Free Report) (TSE:BTO) – Analysts at Cormark upped their Q4 2024 earnings per share estimates for shares of B2Gold in a research note issued to investors on Thursday, May 9th. Cormark... More of this article »
Needham & Company LLC Raises Payoneer Global (NASDAQ:PAYO) Price Target to $8.00
Payoneer Global (NASDAQ:PAYO – Free Report) had its target price increased by Needham & Company LLC from $7.00 to $8.00 in a research note published on Thursday morning, Benzinga reports. Needham & Company LLC currently... More of this article »
Q4 2024 Earnings Forecast for WhiteHorse Finance, Inc. Issued By B. Riley (NASDAQ:WHF)
WhiteHorse Finance, Inc. (NASDAQ:WHF – Free Report) – Equities research analysts at B. Riley dropped their Q4 2024 earnings estimates for WhiteHorse Finance in a report issued on Thursday, May 9th. B. Riley analyst... More of this article »
Q4 2024 EPS Estimates for Sun Life Financial Inc. Decreased by Analyst (TSE:SLF)
Sun Life Financial Inc. (TSE:SLF – Free Report) (NYSE:SLF) – Analysts at National Bank Financial decreased their Q4 2024 earnings per share (EPS) estimates for shares of Sun Life Financial in a report issued on Thursday,... More of this article »
Airbnb, Inc. to Post FY2024 Earnings of $5.09 Per Share, B. Riley Forecasts (NASDAQ:ABNB)
Airbnb, Inc. (NASDAQ:ABNB – Free Report) – Stock analysts at B. Riley increased their FY2024 earnings per share (EPS) estimates for Airbnb in a note issued to investors on Thursday, May 9th. B. Riley analyst N. Khan... More of this article »
Ascend Wellness Holdings, Inc. (OTC:AAWH) Expected to Post FY2024 Earnings of ($0.27) Per Share
Ascend Wellness Holdings, Inc. (OTC:AAWH – Free Report) – Equities research analysts at Cormark cut their FY2024 earnings per share estimates for shares of Ascend Wellness in a report released on Wednesday, May 8th.... More of this article »
ACADIA Pharmaceuticals Inc. Forecasted to Earn FY2024 Earnings of $0.41 Per Share (NASDAQ:ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) – Stock analysts at Cantor Fitzgerald dropped their FY2024 earnings estimates for shares of ACADIA Pharmaceuticals in a research note issued on Thursday, May 9th.... More of this article »
Aclaris Therapeutics, Inc. Expected to Earn FY2024 Earnings of ($0.75) Per Share (NASDAQ:ACRS)
Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Free Report) – Analysts at Cantor Fitzgerald boosted their FY2024 EPS estimates for Aclaris Therapeutics in a note issued to investors on Wednesday, May 8th. Cantor Fitzgerald... More of this article »